AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer

Oncogene

Volumn 22, Issue 51, 2003, Pages 8293-8301

  Jiang, Ying ^a   Zhang, Yongke ^b   Lees, Emma ^a   Seghezzi, Wolfgang ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PROTEIN DESIGN LABS INC   (United States)

Author keywords

Cell cycle; Mitotic kinase; Mitotic spindle checkpoint

Indexed keywords

AURORA A PROTEIN KINASE; ENZYME; NOCODAZOLE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION;

CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICROTUBULES; MITOTIC SPINDLE APPARATUS; NOCODAZOLE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; XENOPUS PROTEINS;

MUS MUSCULUS;

EID: 0345304925     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206873     Document Type: Article

References (40)

1. Adams RR, Carmena M and Earnshaw WC. (2001). Trends Cell Biol., 11, 49-54.
2. Anand S, Penrhyn-Lowe S and Venkitaraman AR. (2003). Cancer Cell, V3, 51-62.
3. Bernard M, Sanseau P, Henry C, Couturier A and Prigent C. (1998). Genomics, 53, 406-409.
4. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ and Plowman GD. (1998). EMBO J., 17, 3052-3065.
5. Chan CS and Botstein D. (1993). Genetics, 135, 677-691.
6. Chan GK, Jablonski SA, Sudakin V, Hittle JC and Yen TJ. (1999). J. Cell Biol., 146, 941-954.
7. Chan GK, Schaar BT and Yen TJ. (1998). J. Cell Biol., 143, 49-63.
8. De Bondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO and Kim SH. (1993). Nature, 363, 595-602.
9. Fang G. (2002). Mol. Biol. Cell, 13, 755-766.
10. Farruggio DC, Townsley FM and Ruderman JV. (1999). Proc. Natl. Acad. Sci. USA, 96, 7306-7311.
11. Giet R and Prigent C. (2000). Exp. Cell Res., 258, 145-151.
12. Glover DM, Leibowitz MH, McLean DA and Parry H. (1995). Cell, 81, 95-105.
13. Hardwick KG. (1998). Trends Genet., 14 (1), 1-4.
14. Hernando E, Orlow I, Liberal V, Nohales G, Benezra R and Cordon-Cardo C. (2001). Int. J. Cancer, 95, 223-227.
15. Hixon ML and Gualberto A. (2000). Front. Biosci., 5, D50-D57.
16. Imai Y, Shiratori Y, Kato N, Inoue T and Omata M. (1999). Jpn. J. Cancer Res., 90, 837-840.
17. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massague J and Pavletich NP. (1995). Nature, 376, 313-320.
18. Kallio MJ, McCleland ML, Stukenberg PT and Gorbsky GJ. (2002). Curr. Biol., 12, 900-905.
19. Khan SH and Wahl GM. (1998). Cancer Res., 58, 396-401.
20. Kufer TA, Sillje HH, Korner R, Gruss OJ, Meraldi P and Nigg EA. (2002). J. Cell Biol., 158, 617-623.
21. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
22. Li W, Lan Z, Wu H, Wu S, Meadows J, Chen J, Zhu V and Dai W. (1999). Cell Growth Differ., 10, 769-775.
23. Littlepage LE and Ruderman JV. (2002). Genes Dev., 16, 2274-2285.
24. Marumoto T, Hirota T, Morisaki T, Kunitoku N, Zhang D, Ichikawa Y, Sasayama T, Kuninaka S, Mimori T, Tamaki N, Kimura M, Okano Y and Saya H. (2002). Genes Cells, 7, 1173-1182.
25. Meraldi P, Honda R and Nigg EA. (2002). EMBO J., 21, 483-492.
26. Murata-Hori M, Tatsuka M and Wang YL. (2002). Mol. Biol. Cell, 13, 1099-1108.
27. Nigg EA. (2001). Nat. Rev. Mol. Cell Biol., 2, 21-32.
28. Ouyang B, Knauf JA, Ain K, Nacev B and Fagin JA. (2002). Clin. Endocrinol (Oxf)., 56, 341-350.
29. Reis RM, Nakamura M, Masuoka J, Watanabe T, Colella S, Yonekawa Y, Kleihues P and Ohgaki H. (2001). Acta Neuropathol. (Berl)., 101, 297-304.
30. Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Shimomura K, Nakamura Y, Inazawa J, Abe T and Yamagishi H. (2001). Br. J. Cancer, 84, 824-831.
31. Sato M, Sekido Y, Horio Y, Takahashi M, Saito H, Minna JD, Shimokata K and Hasegawa Y. (2000). Jpn. J. Cancer Res., 91, 504-509.
32. Sen S, Zhou H and White RA. (1997). Oncogene, 14, 2195-2200.
33. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, Katz RL, Brinkley W and Czerniak B. (2002). J. Natl. Cancer Inst., 94, 1320-1329.
34. Sudakin V, Chan GK and Yen TJ. (2001). J. Cell Biol., 154, 925-936.
35. Takahashi T, Haruki N, Nomoto S, Masuda A, Saji S and Osada H. (1999). Oncogene, 18, 4295-4300.
36. Tang Z, Bharadwaj R, Li B and Yu H. (2001). Dev. Cell, 1 (2), 227-237.
37. Terada Y, Tatsuka M, Suzuki F, Yasuda Y, Fujita S and Otsu M. (1998). EMBO J., 17, 667-676.
38. Walter AO, Seghezzi W, Korver W, Sheung J and Lees E. (2000). Oncogene, 19, 4906-4916.
39. Zhang Y and Lees E. (2001). Mol. Cell Biol., 21, 5190-5199.
40. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR and Sen S. (1998). Nat. Genet., 20, 189-193.